Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product -- Ignore unavailable to you. Want to Upgrade?

To: OpusX who wrote (1355)	7/19/1999 8:14:00 PM
From: Chisy	Respond to of 1837

I maintain that until doctors start prescribing it, it will sit on your shelves for ever. The sales push takes awhile to get to physicians. My doctor is more concerned about bone loss and heart attacks. Until it is proven to be comparable to Premarin lots of luck. I seriously doubt if half the women taking Premarin knows where the ingredients come from. This will come in due time. IMO, we have to look at this as a longer term investment.

To: OpusX who wrote (1355)	7/19/1999 8:21:00 PM
From: bw	Read Replies (1) \| Respond to of 1837

As a past trader and current watcher, I also am not long the stock at present. The upcoming earnings will be bad..but with plenty of positive spin on future earnings improvements, etc.ect... Not unusual, and SOP for a company behind the "debt 8 ball" and going up against the AHP giant.[with their new Cenestin warning insert] Without any real earnings, and a mountain of debt the stock will only spike & languish until their financials get into better shape. Also, if massive sales are imminent, why no broker recommends?